The effect of nortriptyline and its combination with mometasone on secretion of IL-6 and IL-8 by stimulated blood mononuclear cells in vitro

  
Mironova T.V.1 , Taganovich A.D.1, Makarevich V.V.1, Kolesnikova T.S.2, Levandovskaya O.V.3, Shilovsky I.P.4, Khaitov M.R.4, Kadushkin A.G.1

1. Department of Biochemistry, Belarusian State Medical University, Minsk, Republic of Belarus
2. Research Institute of Experimental and Clinical Medicine, Belarusian State Medical University, Borovlyansky, Republic of Belarus
3. Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Republic of Belarus
4. Institute of Immunology, Moscow, Russia
Section: Short Communication
DOI: 10.18097/PBMCR1630     
Year: 2026  Volume: 72  Issue: 1  Pages: 75-79
Glucocorticosteroids (GCS) are often the medication of choice for chronic inflammation. Since not all patients are equally sensitive to GCS, certain efforts are undertaken to increase sensitivity and complement glucocorticosteroid therapy with other nonsteroidal medications that can enhance the anti-inflammatory effect of GCS. The tricyclic antidepressant nortriptyline has demonstrated anti-inflammatory properties in several experimental studies, as well as the ability to complement the action of GCS. The aim of this study was to investigate the effects of nortriptyline, as well as its combination with mometasone, on blood mononuclear cells (MNCs) under conditions of stimulated immune responses (IR) of types 1, 2, and 17. In isolated MNCs from six healthy donors, IR type I, type 2, or type 17 were stimulated in the presence of nortriptyline, mometasone, or their combination by adding recombinant activator proteins (IL-2, IL-25, IL-33, thymic stromal lymphopoietin (TSLP), IL-12, IL-1β, IL-23). After three days, the concentration of IL-6 and IL-8 was determined in the supernatants by enzyme-linked immunosorbent assay. In the presence of nortriptyline at a final concentration of 10–5 M, IR type 2 and type 17 were accompanied by a decrease in IL-6 concentration. Addition of a combination of mometasone and nortriptyline to the MNC culture medium under conditions of IR type II activation had a potentiating effect. This was evidenced by a decrease in IL-6 and IL-8 secretion compared to the use of mometasone alone. The study demonstrates the ability of nortriptyline to suppress the secretion of proinflammatory cytokines by blood cells, which is selective and dependent on the type of immune response.
Download PDF:  
Keywords: IL-6, IL-8, blood cells, immune response
Citation:

Mironova, T. V., Taganovich, A. D., Makarevich, V. V., Kolesnikova, T. S., Levandovskaya, O. V., Shilovsky, I. P., Khaitov, M. R., Kadushkin, A. G. (2026). The effect of nortriptyline and its combination with mometasone on secretion of IL-6 and IL-8 by stimulated blood mononuclear cells in vitro. Biomeditsinskaya Khimiya, 72(1), 75-79.
References  
 2026 (vol 72)
 2025 (vol 71)
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)